Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.580
-0.020 (-1.25%)
At close: Jan 9, 2026, 4:00 PM EST
1.600
+0.020 (1.27%)
After-hours: Jan 9, 2026, 7:14 PM EST
Bionano Genomics Market Cap
Bionano Genomics has a market cap or net worth of $16.08 million as of January 9, 2026. Its market cap has decreased by -21.84% in one year.
Market Cap
16.08M
Enterprise Value
11.69M
1-Year Change
-21.84%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since September 21, 2018, Bionano Genomics's market cap has decreased from $66.34M to $16.08M, a decrease of -75.77%. That is a compound annual growth rate of -17.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 16.08M | 3.27% |
| Dec 31, 2025 | 15.57M | -47.07% |
| Dec 31, 2024 | 29.41M | -59.93% |
| Dec 29, 2023 | 73.41M | -83.07% |
| Dec 30, 2022 | 433.51M | -49.86% |
| Dec 31, 2021 | 864.66M | 83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |